Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 23, 2022

Real-World Study of SGLT2 Inhibitors in Patients With Type 1 Diabetes

Diabetes Care


Additional Info

Diabetes Care
Real-world Evidence of Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
Diabetes Care 2022 Jan 21;[EPub Ahead of Print], A Palanca, F van Nes, F Pardo, FJ Ampudia Blasco, C Mathieu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading